Rhapsody
Enterprise healthcare integration through Rhapsody, Corepoint, and Envoy

Rhapsody provides healthcare integration software and services, including Rhapsody, Corepoint, and Envoy, to connect clinical systems and manage data exchange.
Best for
- Health systems and health technology companies managing complex clinical interfaces
- Organizations needing control over deployment and custom integration workflows
Not ideal for
- Teams expecting an integration engine to eliminate all interface design and maintenance
- Buyers assuming every product, module, and hosting arrangement has the same cost

Bottom line
Rhapsody is a strong option for healthcare organizations that need configurable integration infrastructure and specialist support. It is most useful when the chosen engine and deployment model match the team’s technical capacity and clinical data requirements.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Rhapsody at rhapsody.health serves hospital integration teams and health technology companies connecting clinical applications. Redox is a genuine alternative for healthcare integration, particularly when an organization wants a managed cloud connection model. Rhapsody’s fit becomes stronger where custom workflows, local control, or varied hosting arrangements are central requirements.
This is enterprise infrastructure with software, implementation, training, and ongoing operating costs. Rhapsody and Corepoint are distinct integration products within the same company, while Envoy supplies additional cloud and automation options. A proposal should identify the actual engine, modules, deployment, and service level being compared.
- Outcomes and workflow value (8.2): Detailed healthcare customer accounts support reliability, interface delivery, and support value.
- Product and service depth (8.6): Integration engines, cloud options, automation, and broader data capabilities provide substantial enterprise depth.
- Ease of implementation (7.0): Low-code tools help, but clinical data knowledge, testing, monitoring, and migration remain important.
- Pricing clarity (6.3): The vendor describes fixed subscriptions, while customer accounts show module, training, and maintenance costs need careful comparison.
Integration Capabilities and Deployment Choices
Rhapsody’s current product materials describe Rhapsody, Corepoint, and Envoy as options for healthcare integration. The company offers client-hosted and cloud deployment, with low-code or no-code development capabilities depending on the product. Those choices matter to organizations with both legacy messaging and newer application interfaces.
An engine can receive, transform, route, and monitor data, but the receiving system still needs the correct patient, meaning, and workflow context. Interface specifications, exception handling, and acceptance tests are essential even when development tools reduce the amount of manual coding.
Customer Evidence and Support
KLAS Corepoint comments contain detailed praise for reliability, troubleshooting, and support. One director says the vendor gets back within a day, and other respondents describe quick resolution and useful testing tools. These accounts support the case for a maintained integration product with specialist assistance.
The same comments include concerns about account-manager changes, training options, maintenance increases, and additional module costs. They concern Corepoint experiences and should not be generalized to every Rhapsody product. They are useful prompts for defining support access, renewal terms, and training for staff turnover.
Comparing Rhapsody with Redox
Rhapsody’s own Redox comparison emphasizes custom integration, flexible hosting, and predictable subscriptions. Because it is vendor-authored, its criticisms of Redox are not independent findings. A fair evaluation tests the same endpoints, data formats, service responsibilities, and expected growth with both suppliers.
Rhapsody can suit an organization that wants more direct control over complex integration logic. A managed API-oriented service may suit a team seeking less infrastructure ownership. Migration plans should account for interface inventory, parallel operation, monitoring, and the operational knowledge held by existing staff.
Product and service details: rhapsody.health, klasresearch.com.
Company scale
Similarweb’s September 2026 profile for rhapsody.health estimates annual revenue at $15 million to $25 million. Scale source
What People Say
What people like
"Rhapsody has a very good support model, and they get back to us within a day."
"Rhapsody’s training courses provide an excellent basis for anybody to start using Corepoint."
What people don't like
"It seems like every few months, we get a new Rhapsody account manager, and they never call us."
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Rhapsody | 7.8 | 7.0 |
| Redox | 7.1 | 6.8 |
| Smile Digital Health | 7.1 | 6.6 |
Pricing
| Item | Detail |
|---|---|
| Subscription model | Rhapsody’s March 2026 comparison describes fixed subscription pricing; no public dollar rate is supplied. |
| Modules and services | Specify engine, APIs and web services, hosting, availability, monitoring, migration, training, and support. |
| Renewal costs | Compare maintenance increases, additional interfaces, and staff training over the full agreement. |
Leadership
Recent news
- October 2026: Rhapsody launched Rhapsody Guardian, which authenticates AI agents, enforces scoped access and rate limits, and records agent, MCP, and API activity against health data and services.
- August 2026: Rhapsody made its Payer Interoperability Suite available in the Connection Hub on Epic Showroom for health plans using Epic’s payer platform.
- March 2026: Rhapsody made Rhapsody Axon generally available, an AI agent built into its Rhapsody and Corepoint integration engines for FHIR, HL7v2, X12, and API workflows.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- rhapsody.health · compare rhapsody redox
- klasresearch.com · comments/rhapsody corepoint all/1296
- similarweb.com · company/rhapsody.health
- rhapsody.health · about us
- rhapsody.health ·
